Primary Sclerosing Cholangitis clinical trials at UCSF

1 research study open to eligible people

Primary sclerosing cholangitis causes scarring in the bile ducts of the liver. UCSF is conducting studies to discover what increases the risk of liver issues. These studies aim to predict liver complications in people with this condition.

Showing trials for

  • Liver Cirrhosis Network Cohort Study

    open to eligible people ages 18 years and up

    Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-person visits will include questionnaires, physical exams, imaging, and sample collection.

    San Francisco, California and other locations

Last updated: